The latest research news in genetics and genomics.
The funds will support the companies' efforts to develop tests for predicting NSCLC patients' response to immunotherapy.
An international group of researchers aim to develop an approach that may be able to diagnose multiple conditions, including pneumonia, tuberculosis, sepsis, with one blood sample.
CE marking of PromarkerD Hub complements the CE mark that the mass spectrometry version of the test received in November.
Such an approach could be more specific for Alzheimer's than symptoms-based diagnoses while also allowing for earlier detection and treatment of the condition.
The score's developers also suggest that current guidelines for stroke prevention may not be sufficient for individuals at higher genomic risk for the condition.
